Diabetic Technology & Medication
944 articles
- The Impact of Jdrf on the Innovation Pipeline for Next-generation Insulin Devices
- The Potential of Jdrf-supported Wearable Biosensors in Continuous Monitoring
- How Jdrf Is Supporting Research into T1d and Covid-19 Interactions
- Jdrf’s Efforts to Improve Insulin Pump Technology and User Experience
- Jdrf’s Initiatives to Advance Telehealth and Remote Monitoring Technologies
- Jdrf’s Impact on the Regulatory Pathways for New Diabetes Technologies
- How Jdrf Is Supporting the Development of Wearable Insulin Delivery Systems
- Exploring the Potential of Jdrf-supported Nanotechnology in Diabetes Treatment
- The Role of Jdrf in Supporting Early-stage Startups in Diabetes Technology
- Jdrf's Efforts to Improve Quality of Life for Children with T1d Through Innovative Technologies
- Latest Updates in Insulin Formulations for the Cde Exam
- Understanding the FDA Guidelines for Diabetes Devices for the Cde Exam
- Use of Technology in Diabetes Education for the Cde Certification
- The Role of Patient Education in Passing the Cde Exam
- The Importance of Patient Education in Recognizing Infection Symptoms Early
- Enhancing Teleophthalmology with Pattern Recognition for Diabetic Retina Screening
- How AI-driven Pattern Recognition Supports Personalized Treatment Plans in Diabetic Eye Care
- Pattern Recognition-based Algorithms for Predicting Diabetes Complications
- The Potential of Gene Editing in Creating Autoimmunity-resistant Pancreatic Cells
- Innovations in Delivery of Autoimmune Therapies Using Micro-needle Arrays
- The Potential of Cytokine Engineering in Autoimmune Response Suppression
- The Use of Advanced Biomaterials to Create Immune-privileged Environments for Beta Cells
- Innovative Approaches Using Light-activated Therapies to Modulate Autoimmune Responses
- Progress in Developing Artificial Intelligence-driven Autoimmune Disease Models
- Innovative Approaches to Deliver Autoimmune Therapies via Nanocarriers
- The Future of Bioengineered Pancreatic Tissue in Personalized Diabetes Cure Solutions
- The Use of Synthetic Peptides in Autoimmune Tolerance Induction for T1d
- Innovative Approaches in Developing Universal Donor Islet Cells for Transplantation
- The Use of Biocompatible Scaffolds to Support Islet Cell Transplantation Success
- Exploring the Therapeutic Potential of Mesenchymal Stem Cells in Diabetes